BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology firm advancing the subsequent era of oligonucleotide therapies with the aim of…
Our selection of the week's biggest research news and features sent directly to your inbox. Enter your email address, confirm you're happy to receive our emails.
Please contact salesdepartment
for further information at:
Sales@88.broker
Sign in to your account